0.2065
price down icon1.24%   -0.0025
 
loading
Mustang Bio Inc stock is traded at $0.2065, with a volume of 139.96K. It is down -1.24% in the last 24 hours and down -29.68% over the past month. Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
See More
Previous Close:
$0.209
Open:
$0.21
24h Volume:
139.96K
Relative Volume:
0.08
Market Cap:
$10.29M
Revenue:
-
Net Income/Loss:
$-40.10M
P/E Ratio:
-0.0218
EPS:
-9.46
Net Cash Flow:
$-36.99M
1W Performance:
-12.43%
1M Performance:
-29.68%
6M Performance:
-33.42%
1Y Performance:
-86.51%
1-Day Range:
Value
$0.2039
$0.212
1-Week Range:
Value
$0.2039
$0.24
52-Week Range:
Value
$0.1281
$1.68

Mustang Bio Inc Stock (MBIO) Company Profile

Name
Name
Mustang Bio Inc
Name
Phone
(781) 652-4500
Name
Address
377 PLANTATION STREET, WORCESTER, NY
Name
Employee
80
Name
Twitter
@Mustang_Bio
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
MBIO's Discussions on Twitter

Compare MBIO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MBIO 0.2062 10.29M 0 -40.10M -36.99M -9.46
VRTX 448.26 115.74B 10.63B -479.80M -1.35B 13.33
REGN 745.57 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.39 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.72 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.24 24.49B 3.30B -501.07M 1.03B 11.54

Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades

Date Action Analyst Rating Change
May-18-21 Initiated BTIG Research Buy
Oct-02-20 Initiated B. Riley FBR Buy
Nov-20-19 Initiated Cantor Fitzgerald Overweight
Aug-13-19 Initiated H.C. Wainwright Buy
Jun-21-19 Initiated Cantor Fitzgerald Overweight
Dec-21-17 Initiated Oppenheimer Outperform
View All

Mustang Bio Inc Stock (MBIO) Latest News

pulisher
Nov 15, 2024

Mustang Bio's Interim CFO Resigns After 10 Months - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio Faces Nasdaq Delisting and Leadership Changes - TipRanks

Nov 15, 2024
pulisher
Nov 15, 2024

Mustang Bio, Inc. Announces CFO Changes - Marketscreener.com

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Mustang Bio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Fortress Biotech Inc. (FBIOP) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance By Investing.com - Investing.com South Africa

Nov 12, 2024
pulisher
Nov 12, 2024

Crude Oil Brent (F) (QAX25) Quote - The Globe and Mail

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio gets extension for Nasdaq compliance - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Receives Positive Listing Determination from Nasdaq - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Mustang Bio Secures Critical Nasdaq Extension, Faces January 2025 Deadline for $1 Compliance | MBIO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 10, 2024

Virus Therapy Gets Orphan Drug Designation for Glioma Treatment - www.oncnursingnews.com/

Nov 10, 2024
pulisher
Nov 08, 2024

Mustang Bio Inc (MBIO) Quarterly 10-Q Report - Quartzy

Nov 08, 2024
pulisher
Nov 08, 2024

Mustang Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 08, 2024
pulisher
Nov 08, 2024

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Toll Brothers Inc (TOL-N) QuotePress Release - The Globe and Mail

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio gains FDA Orphan Drug Status for glioma treatment By Investing.com - Investing.com UK

Nov 07, 2024
pulisher
Nov 07, 2024

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - Yahoo Finance

Nov 07, 2024
pulisher
Nov 06, 2024

Mustang Bio sets annual meeting date, deadlines for proposals - Investing.com

Nov 06, 2024
pulisher
Nov 06, 2024

Everquote Inc Cl A (EVER-Q) QuotePress Release - The Globe and Mail

Nov 06, 2024
pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 27, 2024

Data Readouts At EHA Congress 2021 (APTO, XFOR, GBT, CRIS…) - RTTNews

Oct 27, 2024
pulisher
Oct 26, 2024

Mustang Bio Secures $4M through Strategic Warrant Agreement - Yahoo Finance

Oct 26, 2024
pulisher
Oct 26, 2024

Revance Therapeutics Inc’s (RVNC) Stock Is Harder To Predict Than You Think - Stocks Register

Oct 26, 2024
pulisher
Oct 25, 2024

Mustang Bio, Inc. Appoints David Jin as A Member of the Board - Marketscreener.com

Oct 25, 2024
pulisher
Oct 25, 2024

Mustang Bio secures $4 million from warrant exercises - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Mustang Bio secures $4 million from warrant exercises By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - GlobeNewswire

Oct 24, 2024
pulisher
Oct 23, 2024

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 23, 2024
pulisher
Oct 14, 2024

Chimeric Antigen Receptor T (CAR-T) Cells Market Research Analysis 2024-2033 | Growth, Size, Analysis, Insi... - WhaTech

Oct 14, 2024
pulisher
Oct 09, 2024

Investor’s Toolkit: Key Ratios for Assessing Mustang Bio Inc (MBIO)’s Performance - The Dwinnex

Oct 09, 2024
pulisher
Sep 30, 2024

A stock that deserves closer examination: Mustang Bio Inc (MBIO) - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket - MSN

Sep 27, 2024
pulisher
Sep 26, 2024

Mustang Bio Inc (MBIO) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

There is no doubt that Mustang Bio Inc (MBIO) ticks all the boxes. - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

Marshall Wace LLP Has $92.82 Million Position in StoneCo Ltd. (NASDAQ:STNE) - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug - Yahoo Finance

Sep 24, 2024
pulisher
Sep 24, 2024

Market Update: Mustang Bio Inc (MBIO) Sees Negative Movement, Closing at 0.21 - The Dwinnex

Sep 24, 2024
pulisher
Sep 23, 2024

Mustang Bio (MBIO) Stock Price, News & Analysis - MarketBeat

Sep 23, 2024
pulisher
Sep 20, 2024

Wild mustangs available for adoption in Cullman County - WVTM13 Birmingham

Sep 20, 2024
pulisher
Sep 20, 2024

MBIO’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle

Sep 20, 2024
pulisher
Sep 20, 2024

Daily Market Movement: Mustang Bio Inc (MBIO) Sees a -12.17 Decrease, Closing at 0.22 - The Dwinnex

Sep 20, 2024
pulisher
Sep 20, 2024

Review: The striking, confident 2025 Ford Mustang, reimagined for the modern era - MarketWatch

Sep 20, 2024
pulisher
Sep 19, 2024

DEADLINE ALERT for OM, SAGE, and SMCI: The Law Offices of - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Drugmaker for rare disease soars 1,200% in last year - Kursiv Media

Sep 19, 2024
pulisher
Sep 18, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

Worcester biopharma faces delisting from Nasdaq - Worcester Business Journal

Sep 18, 2024
pulisher
Sep 18, 2024

Bokf Na Purchases 2,755 Shares of USANA Health Sciences, Inc. (NYSE:USNA) - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

As Interest in EVs Ebbs, Ford Reveals its Fastest, Most Powerful Mustang Ever- the 2025 Mustang GTD - Torque News

Sep 17, 2024
pulisher
Sep 17, 2024

Ford To Roll Out Limited Edition Street Legal Race Car Variant Of Mustang As Early As This Year - MSN

Sep 17, 2024

Mustang Bio Inc Stock (MBIO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):